Clinical Trials in Denver

Showing 6801-6820 of 18,161 trials

A Study of Repotrectinib in Combination With Other Anticancer Therapies for the Treatment of Subjects With KRAS-Mutant Solid Tumors

NCT05071183

A Phase 1b/2 Study of Repotrectinib in Combination with Other Anticancer Therapies for the Treatment of Subjects with KRAS-Mutant Advanced Solid Tumors (TRIDENT-2)

KRAS Mutation-Related TumorsMetastatic Solid TumorAdvanced Solid Tumor

Turning Point Therapeutics, Inc.9 participantsStarted Sep 2021

California City, California, United States • California City, California, United States • Denver, Colorado, United States +3 more locations

COMPLETEDPhase 3< 1 mile

Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat in Non-Dialysis Subjects Evaluating Hemoglobin (Hgb) and Quality of Life (ASCEND-NHQ)

NCT03409107

The purpose of this multi-center study in non-dialysis participants with anemia associated with CKD is to evaluate safety, efficacy and quality of life of daprodustat compared to placebo.

Anaemia

GlaxoSmithKline614 participantsStarted Mar 2018

Homewood, Alabama, United States • Little Rock, Arkansas, United States • Downey, California, United States +165 more locations

A Study of Repotrectinib in Combination With Other Anticancer Therapies for the Treatment of Subjects With KRAS-Mutant Solid Tumors

Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat in Non-Dialysis Subjects Evaluating Hemoglobin (Hgb) and Quality of Life (ASCEND-NHQ)

Find Trials by Condition in Denver

PREDICT Trial: PRospective Evaluation of NTM Disease In CysTic Fibrosis

Longitudinal Innate Immunity and Aging Study

Effects of Augmented Renal Clearance on Pharmacokinetic and Pharmacodynamic Properties of Levetiracetam in Subarachnoid Hemorrhage

Improving Function in Older Veterans With Hospital-Associated Deconditioning

A Study to Evaluate the Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of TAK-079 in Combination With Standard Background Therapy in Participants With Moderate to Severe Systemic Lupus Erythematosus (SLE)

Multiple Cardiac Sensors for the Management of Heart Failure

Critical Illness Myopathy and Trajectory of Recovery in AKI Requiring CRRT

Study of IDO Inhibitor and Temozolomide for Adult Patients With Primary Malignant Brain Tumors

Efficacy and Safety of CBP-201 in Patients With Moderate to Severe Persistent Asthma With Type 2 Inflammation

Study of Magrolimab (Hu5F9-G4) in Combination With Avelumab in Solid Tumor Participants and Checkpoint-Inhibitor-Naive Ovarian Cancer Participants Who Progress Within 6 Months of Prior Platinum Chemotherapy

Study to Evaluate Itraconazole Administered as Inhaled Dry Powder in Adults With Asthma and ABPA

A Study to Compare the Efficacy and Safety of Lisocabtagene Maraleucel vs Investigator's Choice Options in Adult Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, Whose Disease Has Failed Treatment With Both BTKi and BCL2i Therapies

Study With Seletracetam (Ucb 44212) in Adult Subjects (18 to 65 Years) With Partial Onset Seizures

Effect of CREON on Exocrine Pancreatic Insufficiency (EPI) Symptoms

A Study of Pirtobrutinib (LY3527727 [LOXO-305]) Versus Placebo in Participants With Relapsing Multiple Sclerosis

REDAPT Retrospective-Prospective Modular Stem Study

Safety of Ruconest in 2-13 Year Old Hereditary Angioedema (HAE) Patients

Pilot Study of Nivolumab in Pediatric Patients With Hypermutant Cancers